Clinical trial of sodium selenite in patient with selenium deficiency

Clinical trial of sodium selenite in patient with selenium deficiency - Clinical trial of sodium selenite for selenium deficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027883

Enrollment

Registered

2017-07-01

Start date

2016-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

selenium deficiency

Interventions

sodium selenite at 100 to 200 micro g/day at day 1-7 in a week,4-week interval assessment. continued till symptoms associated with selenium deficiency were recuperated.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients at the age of 20 years or more during management of intravenous alimentation for one month or more 2.low serum concentration of selenium 3.written consent obtained 4. patients unable to have selenium supplementation per orally 5.likely appearance of symptoms suggestive of selenium deficiency if no selenium supplementation is continued 6. for inpatients and outpatients

Exclusion criteria

Exclusion criteria: 1.patients allergy to sodium selenite 2.outpatients unable to communicate with others at emergency.

Design outcomes

Primary

Measure	Time frame
improvement of visual and sensory disturbance at 4 weeks after sodium selenite was started	—

Secondary

Measure	Time frame
improvement of low serum selenium concentration at 4 weeks	—

Countries

Japan

Contacts

Public ContactSatoshi Tanida

Nagoya City University Graduate School of Medical Sciences Gastroenterology and Metabolism

stanida@med.nagoya-cu.ac.jp052-853-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026